You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Multiple Sclerosis/ Demyelinating Disease

Citations 301-310 of 328 total displayed.

Past content (since Jan 1998):

Controversies in Neurology
Intravenous Immunoglobulin Treatment in Neurologic Disorders: Yes
Per Soelberg Sorensen
Arch Neurol 1999; 56: 1025-1027. [Extract] [Full text] [PDF]  

Controversies in Neurology
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?: No
Dimitrios Karussis; Oded Abramsky
Arch Neurol 1999; 56: 1028-1032. [Extract] [Full text] [PDF]  

Controversies in Neurology
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Vladimir Hachinski
Arch Neurol 1999; 56: 1032. [Extract] [Full text] [PDF]  

Neurological Reviews
Mechanisms of High-Dose Intravenous Immunoglobulins in Demyelinating Diseases
Martin Stangel; Klaus V. Toyka; Ralf Gold
Arch Neurol 1999; 56: 661-663. [Abstract] [Full text] [PDF]  

Original Contributions
Urinary Myelin Basic Protein–like Material in Patients With Multiple Sclerosis During Interferon Beta-1b Treatment
John N. Whitaker; Beverly A. Layton; Alfred A. Bartolucci; Galen W. Mitchell; Khurram Bashir; Jeanine Goodwin; R. David Kachelhofer
Arch Neurol 1999; 56: 687-691. [Abstract] [Full text] [PDF]  

Observations
Trigeminal Neuralgia Triggered by Auditory Stimuli in Multiple Sclerosis
Mathias Hartmann; Klaus G. Rottach; Walter A. Wohlgemuth; Karl Pfadenhauer
Arch Neurol 1999; 56: 731-733. [Abstract] [Full text] [PDF]  

Original Contributions
HLA Class II Susceptibility to Multiple Sclerosis Among Ashkenazi and Non-Ashkenazi Jews
Oh Joong Kwon; Arnon Karni; Shoshana Israel; Chaim Brautbar; Avraham Amar; Zeev Meiner; Oded Abramsky; Dimitrios Karussis
Arch Neurol 1999; 56: 555-560. [Abstract] [Full text] [PDF]  

Neurological Reviews
Multiple Sclerosis: Therapeutic Update
Alexandros C. Tselis; Robert P. Lisak
Arch Neurol 1999; 56: 277-280. [Extract] [Full text] [PDF]  

Original Contributions
Elevated Levels of Antibody to Myelin Oligodendrocyte Glycoprotein Is Not Specific for Patients With Multiple Sclerosis
Arnon Karni; Ronit Bakimer-Kleiner; Oded Abramsky; Avraham Ben-Nun
Arch Neurol 1999; 56: 311-315. [Abstract] [Full text] [PDF]  

Original Contributions
Neuropsychologic Status in Multiple Sclerosis After Treatment With Glatiramer
Amy Weinstein; Steven I. L. Schwid; Randolph B. Schiffer; Michael P. McDermott; Daniel W. Giang; Andrew D. Goodman
Arch Neurol 1999; 56: 319-324. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Multiple Sclerosis/ Demyelinating Disease
 collections from JAMA & Archives Journals.
 •Related collections:
  •Neurology
  •Alzheimer Disease
  •Amyotrophic Lateral Sclerosis
  •Ataxia
  •Behavioral Neurology
  •Cerebrovascular Disease
  •Cognitive Disorders
  •Coma/ Vegetative State
  •Deep Brain Stimulation
  •Dementias
  •EEG
  •Encephalitis
  •Epilepsy
  •Headache
  •Lewy Body Disease
  •Meningitis
  •Migraine
  •Motor Neuron Disease
  •Movement Disorders
  •Multiple Sclerosis/ Demyelinating Disease
  •Myasthenia Gravis
  •Neurocutaneous Diseases
  •Neuroendocrinology
  •Neurogenetics
  •Neuromuscular diseases
  •Neuro-ophthalmology
  •Neuro-otology
  •Neuropathology
  •Neurotoxicology
  •Parkinson Disease/ Parkinsonian Disorders
  •Pediatric Neurology
  •Pick Disease
  •Prion Diseases
  •Seizures, Nonepileptic
  •Stroke
  •Tremor
  •Neurology, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.